Sean R Holihan

Title: The Innovative Contributions of Sean R Holihan

Introduction

Sean R Holihan is a notable inventor based in Dayton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for producing crystalline compounds. His work has implications for the production of important medicinal substances.

Latest Patents

Holihan holds a patent for a process titled "Process for crystallizing a 4-azasteroid 5alpha-reductase inhibitor." This invention provides a method for producing crystalline 4,7.beta.-dimethyl-4-aza-5.alpha.-cholestan-3-one from its oil form. The crystallization process involves controlled agitation and specific temperature management. Notably, Holihan's research has identified at least two novel polymorphic nonsolvated forms of the compound, referred to as Form I and Form II. Form I can be prepared in pure form through careful control of the crystallization process.

Career Highlights

Holihan is associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to advancements in pharmaceutical processes and product development. His expertise in crystallization techniques has been instrumental in enhancing the quality and efficacy of medicinal compounds.

Collaborations

Throughout his career, Holihan has collaborated with esteemed colleagues, including Andrew L Forman and Guy R Humphrey. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Sean R Holihan's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his role as a key inventor. His work continues to influence the development of important medicinal compounds, showcasing the impact of innovation in healthcare.